Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-c-Kit/MMAE antibody-drug conjugate NN3201

An antibody-drug conjugate (ADC) composed of 2G4, a human monoclonal antibody directed against the stem cell factor receptor c-Kit (SCFR; KIT; CD117), conjugated to the auristatin derivative and microtubule-disrupting cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic activity. Upon administration of anti-c-Kit/MMAE ADC NN3201, the 2G4 antibody targets and binds to the cell surface antigen c-Kit. Upon binding and internalization, MMAE binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and induces apoptosis in c-Kit-expressing tumor cells. c-Kit, a transmembrane protein and receptor tyrosine kinase (RTK) overexpressed in various solid tumors and hematological malignancies, plays a key role in the regulation of cell differentiation and proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-c-Kit ADC NN3201
anti-c-Kit antibody-drug conjugate NN3201
anti-c-Kit/MMAE ADC NN3201
anti-CD117 ADC NN3201
anti-CD117 antibody-drug conjugate NN3201
anti-CD117/MMAE ADC NN3201
anti-CD117/MMAE antibody-drug conjugate NN3201
Code name:NN 3201
NN-3201
NN3201
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search